Trexquant Investment LP Day One Biopharmaceuticals, Inc. Transaction History
Trexquant Investment LP
- $7.59 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding DAWN
# of Institutions
181Shares Held
84.1MCall Options Held
148KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$96.2 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$78.6 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$71.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$59.6 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$55.4 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $898M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...